(P120) Pregnancy and Parenthood in Radiation Oncology, Views and Experiences Survey (PROVES): Results of a Blinded Prospective Trainee Parenting and Career Development Assessment

OncologyOncology Vol 29 No 4_Suppl_1
Volume 29
Issue 4_Suppl_1

Pregnancy and parenthood are common during residency. Women are responsible for more childcare duties than men but have similar research productivity and career aspirations. Further follow-up is necessary to determine the relationship between pregnancy and parenthood over time.

Emma B. Holliday, Awad A. Ahmed, Reshma Jagsi, Natalie Clark, Wendy A. Woodward, Clifton D. Fuller, Charles R. Thomas, Jr; UT MD Anderson Cancer Center; UT Southwestern Medical Center; University of Michigan; Oregon Health and Science University Knight Cancer Institute

BACKGROUND: Medical school and residency span nearly a decade, during which many students and residents traditionally begin families. As the number of women entering medicine increases, the effects of pregnancy and childbearing on residency experience, research productivity, and career aspirations should be explored. Although men increasingly share childrearing responsibilities in the modern era, recognizing gender differences in time spent in childcare duties and the potential effect on residency experience is paramount to understanding the generational evolution of modern family dynamics for physician-led families.

METHODS: An anonymous, voluntary, 102-item online survey was distributed via email to 540 current radiation oncology residents and 2014 graduates. Respondents were asked about demographics, marital and parental status, pregnancy during residency, publication productivity, career aspirations, and experiences working with pregnant co-residents. Respondents with children were additionally asked about childcare arrangements. Women who had been pregnant during residency were further asked questions regarding radiation safety, maternity leave, and breastfeeding experiences.

RESULTS: A total of 190 respondents completed the survey-107 (56.3%) men and 84 (43.7%) women-for a 35.2% response rate; 97 respondents (51.1%) were parents, and 84 (44.2%) reported that they or their spouse/partner had become pregnant during residency. Also, 52 women (54.2%) and 31 men (33%) (P = .003) reported delaying starting a family due to residency-related reasons. Respondents with children were more often male (65% vs 47.3%; P = .014), were in a higher level of training (79.3% vs 54.8% of respondents were PGY4 or higher; P = .001), were older (median age 32 yr, interquartile range [IQR]: 31–35 yr vs 30, IQR: 29–33 y; P < .001), had a PhD (33% vs 19.3%; P = .033), were married (99% vs 43%; P < .001), and had a spouse/partner who did not work (24.7% vs 1.9%; P < .001). There was no difference in the number of manuscripts published or expressed likelihood of pursing an academic career by parental status. Among parents, men more often had spouses/partners who did not work (38.1% vs 0%; P < .001), reported that their spouse/partner performed a greater percentage of childcare duties (70%, IQR: 60%–80% vs 35%, IQR: 20%–50%; P < .001), and reported that their spouse/partner was more likely to take care of unexpected childcare duties (74.6% vs 31%; P < .001). Common concerns expressed by women with children included radiation safety, maternity leave, breastfeeding, and effects of pregnancy on clinical training, research experience, and their co-residents’ workload.

CONCLUSIONS: Pregnancy and parenthood are common during residency. Women are responsible for more childcare duties than men but have similar research productivity and career aspirations. Further follow-up is necessary to determine the relationship between pregnancy and parenthood over time.

Proceedings of the 97th Annual Meeting of the American Radium Society - americanradiumsociety.org

Articles in this issue

(P005) Ultrasensitive PSA Identifies Patients With Organ-Confined Prostate Cancer Requiring Postop Radiotherapy
(P001) Disparities in the Local Management of Breast Cancer in the United States According to Health Insurance Status
(P002) Predictors of CNS Disease in Metastatic Melanoma: Desmoplastic Subtype Associated With Higher Risk
(P003) Identification of Somatic Mutations Using Fine Needle Aspiration: Correlation With Clinical Outcomes in Patients With Locally Advanced Pancreatic Cancer
(P004) A Retrospective Study to Assess Disparities in the Utilization of Intensity-Modulated Radiotherapy (IMRT) and Proton Therapy (PT) in the Treatment of Prostate Cancer (PCa)
(S001) Tumor Control and Toxicity Outcomes for Head and Neck Cancer Patients Re-Treated With Intensity-Modulated Radiation Therapy (IMRT)-A Fifteen-Year Experience
(S003) Weekly IGRT Volumetric Response Analysis as a Predictive Tool for Locoregional Control in Head and Neck Cancer Radiotherapy 
(S004) Combination of Radiotherapy and Cetuximab for Aggressive, High-Risk Cutaneous Squamous Cell Cancer of the Head and Neck: A Propensity Score Analysis
(S005) Radiotherapy for Carcinoma of the Hypopharynx Over Five Decades: Experience at a Single Institution
(S002) Prognostic Value of Intraradiation Treatment FDG-PET Parameters in Locally Advanced Oropharyngeal Cancer
(P006) The Role of Sequential Imaging in Cervical Cancer Management
(P008) Pretreatment FDG Uptake of Nontarget Lung Tissue Correlates With Symptomatic Pneumonitis Following Stereotactic Ablative Radiotherapy (SABR)
(P009) Monte Carlo Dosimetry Evaluation of Lung Stereotactic Body Radiosurgery
(P010) Stereotactic Body Radiotherapy for Treatment of Adrenal Gland Metastasis: Toxicity, Outcomes, and Patterns of Failure
(P011) Stereotactic Radiosurgery and BRAF Inhibitor Therapy for Melanoma Brain Metastases Is Associated With Increased Risk for Radiation Necrosis
Related Videos
Considering cystectomy in patients with bladder cancer may help with managing the shortage of Bacillus Calmette-Guerin, according to Joshua J. Meeks, MD, PhD, BS.
Anemia in patients who receive talazoparib plus enzalutamide for metastatic castration-resistant prostate cancer appears to be manageable without any compromises in patient-reported outcomes and quality of life.
Patients with locally advanced or metastatic urothelial cancer and visceral disease may particularly benefit from enfortumab vedotin plus pembrolizumab, according to Amanda Nizam, MD.
High-grade adverse effects with zanidatamab plus palbociclib and fulvestrant seem to be uncommon in patients with HER2-positive, hormone receptor–positive, metastatic breast cancer, according to Sara Hurvitz, MD, FACP.
Black male patients with breast cancer appear to experience worse survival outcomes compared with White patients when controlling for clinicopathological variables, according to Jason (Jincong) Q. Freeman, MPH, MS.
Results from the ECOG-ACRIN E4112 trial appear to support the use of DCIS scores for identifying patients with breast cancer who may be eligible to omit radiotherapy following MRI-guided surgery.
Providers should inform patients with breast cancer that selecting later-line therapies following prior treatment with CDK4/6 inhibitors is a “developing area,” says Abigail M. Johnston, JD.
Data from the phase 3 NATALEE trial highlight a positive toxicity profile for ribociclib as an adjuvant therapy for patients with hormone receptor–positive, HER2-negative breast cancer, says Neil M. Iyengar, MD.
Future research will focus on ctDNA dynamics change over time in the full translational cohort of patients with hormone receptor–positive breast cancer in the phase 3 monarchE study, says Stephanie L. Graff, MD.
Findings from a National Cancer Database analysis highlight no statistically significant differences in survival outcomes with chemotherapy for patients over 81 years old with triple-negative breast cancer compared with those who do not receive chemotherapy.
Related Content